Nucleai, Mayo Clinic partner on digital pathology
June 8, 2023 -- Nucleai and Mayo Clinic BioPharma Diagnostics on Monday announced a strategic collaboration involving digital pathology solutions, technologies, and services to support drug development and clinical practice. Read More
Adaptive Biotechnologies, Genentech announce FDA acceptance of investigational new drug application
May 9, 2023 -- Adaptive Biotechnologies on Tuesday announced that the U.S. Food and Drug Administration (FDA) has accepted an investigational new drug (IND) application submitted by its collaborator, Genentech, for a neoantigen-directed T-cell receptor (TCR)-based T-cell therapy. Read More
Roche launches Institute of Human Biology for human model systems to advance research and drug development
May 5, 2023 -- Roche on Thursday announced the launch of the Institute of Human Biology (IHB), focused on advancing medical research through human model systems such as organoids. Using human model systems, the IHB aims to accelerate drug discovery and development through understanding how diseases develop and organs function. Read More
SomaLogic CEO steps down; Q4 revenue declines 18%
March 31, 2023 -- Aptamer-based proteomics firm SomaLogic said after the close of the market on Tuesday that its fourth-quarter revenue declined 18% year over year, primarily due to the recognition of $1.9 million of licensing revenue in the fourth quarter of 2021. Read More
Mayo Clinic Laboratories, Helix collaborate to provide suite of laboratory services to biopharma customers
January 10, 2023 -- Mayo Clinic Laboratories and Helix on Tuesday announced a strategic collaboration that will provide biopharma customers access to a comprehensive joint laboratory offering for research and development initiatives across the drug development lifecycle. Read More
Berkeley Lights launches optofluidic system
January 10, 2023 -- Berkeley Lights, Inc., a life sciences tools company, announced the launch of the Beacon Select, its two-chip, single-cell optofluidic system for cell line development (CLD). Read More
Protillion Biosciences raises $18M in financing to support therapeutic biomarker discovery
December 19, 2022 -- Protillion Biosciences, a privately held biotech company launched in 2019 to identify and optimize new protein therapeutics, on Monday announced the completion of an $18 million Series A financing from Arch Venture Partners and Illumina Ventures. Read More
MinervaX announces funding for Group B Streptococcus vaccine
December 15, 2022 -- Danish biotechnology company MinervaX ApS announced the completion of a 72-million-euro ($76.3 million) financing round to advance development of a novel vaccine against Group B Streptococcus (GBS). An equity financing of 22 million euros was co-led by new investors Trill Impact Ventures and Pureos Bioventures and existing investors. The European Investment Bank provided additional funding in a form of a 50-million-euro loan. Read More
Vegetables contain ‘garden variety’ cancer drugs
December 8, 2022 -- Polish scientists have revealed the potential for new cancer drugs formulated from nightshade plants (genus Solanum), including potatoes and eggplants. Read More
Rice University lab receives $3M grant to develop HIV treatment
December 6, 2022 -- Researchers from Rice University have been awarded a $3 million grant from the Bill & Melinda Gates Foundation to develop a once-a-year treatment for HIV and other infectious diseases. Read More
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter